[
  {
    "ts": null,
    "headline": "Can Charles River (CRL) Redefine Its Competitive Edge Through Science Partnerships and Non-Animal Testing?",
    "summary": "In recent days, Charles River Laboratories International announced several new collaborations, including with The Francis Crick Institute to accelerate Antibody-Drug Conjugate development and with X-Chem to expand access to its proprietary DNA-encoded library platform for hit identification in drug discovery. These collaborations, along with the launch of a global Scientific Advisory Board for alternative testing methodologies, highlight Charles River's commitment to innovation in drug...",
    "url": "https://finnhub.io/api/news?id=45bd7a9d7e47cd5bd225ccca9c15132e59530d15d26788e60f19f8d9845a7fcc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761146071,
      "headline": "Can Charles River (CRL) Redefine Its Competitive Edge Through Science Partnerships and Non-Animal Testing?",
      "id": 137189234,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "In recent days, Charles River Laboratories International announced several new collaborations, including with The Francis Crick Institute to accelerate Antibody-Drug Conjugate development and with X-Chem to expand access to its proprietary DNA-encoded library platform for hit identification in drug discovery. These collaborations, along with the launch of a global Scientific Advisory Board for alternative testing methodologies, highlight Charles River's commitment to innovation in drug...",
      "url": "https://finnhub.io/api/news?id=45bd7a9d7e47cd5bd225ccca9c15132e59530d15d26788e60f19f8d9845a7fcc"
    }
  },
  {
    "ts": null,
    "headline": "Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development",
    "summary": "WILMINGTON, Mass., October 22, 2025--Charles River Laboratories International, Inc. (NYSE: CRL) and The Francis Crick Institute (Crick) today announced a new collaboration around Antibody-Drug Conjugate (ADC) drug discovery and development, leveraging combined strengths to accelerate the development and delivery of next-generation targeted therapies.",
    "url": "https://finnhub.io/api/news?id=cc27bcf940e8acb33d588bf385326265ae8a8c510812e572555781aced9c024f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761134400,
      "headline": "Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development",
      "id": 137189236,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "WILMINGTON, Mass., October 22, 2025--Charles River Laboratories International, Inc. (NYSE: CRL) and The Francis Crick Institute (Crick) today announced a new collaboration around Antibody-Drug Conjugate (ADC) drug discovery and development, leveraging combined strengths to accelerate the development and delivery of next-generation targeted therapies.",
      "url": "https://finnhub.io/api/news?id=cc27bcf940e8acb33d588bf385326265ae8a8c510812e572555781aced9c024f"
    }
  }
]